CLINICAL_TRIALS
trial_result
· 2010-09-28
Clinical Trial Update: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb [Phase 3]
Summary
Phase 3 trial comparing incobotulinumtoxinA (Xeomin) to placebo for post-stroke upper limb spasticity completed; results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merz Pharmaceuticals GmbH | Conditions: Post-stroke Upper Limb Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2010-09-28